From the Desk of the CEO

FDA’s approval of lenacapavir (Yeztugo—Gilead) this summer marked a potential turning point in the fight against HIV.

Kristin Wiisanen PharmD, FAPhA, FCCP, Pharmacy Today editor in chief

Diagnoses of Alzheimer disease and dementia are on the rise. With an estimated 7.2 million Americans currently living with Alzheimer disease—a number expected to nearly double by 2060—the role of pharmacists in Alzheimer care has never been more critical.

Kristin Wiisanen PharmD, FAPhA, FCCP, Pharmacy Today editor in chief

As cannabis use becomes increasingly normalized across the United States, pharmacists stand at a critical junction between patient safety and evolving policy.

Kristin Wiisanen PharmD, FAPhA, FCCP, Pharmacy Today editor in chief

When Hurricane Helene ravaged several southeastern and mid-Atlantic states in September 2024, its aftermath was catastrophic—historic flooding, power outages, and communities thrown into chaos.

Kristin Wiisanen PharmD, FAPhA, FCCP, Pharmacy Today editor in chief

Untreated age-related hearing loss is a major health and social problem, and nearly 30 million U.S. adults could benefit from hearing aids.

Kristin Wiisanen PharmD, FAPhA, FCCP, Pharmacy Today editor in chief